Maynard Um
-
-
-
-
-
-
-
Wells Fargo Upgrades United Therapeutics Corp. (UTHR) to Overweight
-
-
-
-
-
-
-
United Therapeutics receives FDA regenerative medicine designation for liver device
-
-
-
-
-
-
-
Morgan Stanley on United Therapeutics Corp. (UTHR): project Tyvaso '2030/2035 risk-adjusted sales in IPF of $1.2bn/$2.5bn'
-
-
-
-
-
-
-
United Therapeutics Corp. (UTHR) PT Raised to $705 at UBS
-
-
-
-
-
-
-
United Therapeutics Corp. (UTHR) PT Raised to $575 at TD Cowen
-
-
-
-
-
-
-
BTIG on United Therapeutics Corp. (UTHR): 'we would love to see data post-launch on the cadence of adoption, both in PAH and PH-ILD'
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on United Therapeutics Corp. (UTHR)
-
410,548 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

